# Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira

> **NCT00761514** · PHASE4 · TERMINATED · sponsor: **Abbott** · enrollment: 14 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Humira (adalimumab)

## Key facts

- **NCT ID:** NCT00761514
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The study was terminated due to low enrollment.
- **Last updated:** 2009-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761514, "Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00761514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*